300% Aktienanstieg:
Warum diese Kupferstory noch besser wird!
Anzeige
CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion
21,18 EUR
+0,47 %+0,10
5. Nov, 08:51:26 Uhr,
Lang & Schwarz
Kommentare 95
Summer.76,
24.03.2022 20:07 Uhr
0
https://www.globenewswire.com/news-release/2022/03/24/2409242/0/en/CareDx-s-AlloCare-App-Now-Integrated-with-TxAccess-to-Help-Pre-Transplant-Patients-Navigate-the-Waitlist-Process.html
Summer.76,
15.03.2022 9:25 Uhr
0
CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; ...
https://www.bakersfield.com/ap/news/caredx-wins-44-9m-in-damages-in-false-advertising-trial-against-natera-natera-intentionally/article_8849930e-0d01-591f-b643-3ba8c4035548.html
Summer.76,
03.03.2022 15:13 Uhr
0
CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients
https://www.globenewswire.com/news-release/2022/03/03/2396118/31386/en/CareDx-Announces-Cibiltech-Initiates-CIBIL-Study-Using-iBox-Artificial-Intelligence-to-Monitor-Kidney-Transplant-Patients.html
Results from CareDx’s OKRA Study and Cibiltech’s CIBIL Study will Demonstrate Clinical Utility of iBox for Transplant Patient Management
Summer.76,
02.03.2022 13:40 Uhr
0
https://www.globenewswire.com/news-release/2022/03/02/2395224/31386/en/CareDx-Partners-with-the-National-Kidney-Foundation-to-Advocate-for-Kidney-Transplant-Patients.html
Summer.76,
24.02.2022 22:06 Uhr
0
CareDx Reports Fourth Quarter and Full Year 2021 Results
https://www.streetinsider.com/dr/news.php?id=19673878&gfv=1
Summer.76,
22.02.2022 18:11 Uhr
0
CareDx Leads the Way in Xenotransplant Organ Surveillance in Monitoring World’s First Successful Living Xenotransplantation
https://www.globenewswire.com/news-release/2022/02/22/2389123/31386/en/CareDx-Leads-the-Way-in-Xenotransplant-Organ-Surveillance-in-Monitoring-World-s-First-Successful-Living-Xenotransplantation.html
CareDx’s Innovative, Non-Invasive Blood Tests Are Being Used as a Critical Tool to Help Assess Organ Health
Summer.76,
07.02.2022 15:37 Uhr
0
CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education ...
https://www.bakersfield.com/ap/news/caredx-joins-forces-with-mottep-the-national-minority-organ-tissue-transplant-education/article_155404b3-04ad-5e7e-9d14-9e05ff4e7371.html
Summer.76,
16.12.2021 15:43 Uhr
0
CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient Outcomes
https://www.globenewswire.com/news-release/2021/12/16/2353476/31386/en/CareDx-Enrolls-First-Patient-in-LungCare-Registry-Study-to-Measure-Impact-of-Multimodality-Assessment-on-Lung-Transplant-Patient-Outcomes.html
1,000 Patient ALAMO Study will Evaluate the Clinical Utility of LungCare to Detect Transplant Infection and Rejection
Summer.76,
13.12.2021 17:10 Uhr
0
https://www.globenewswire.com/news-release/2021/12/13/2350640/31386/en/CareDx-Partners-with-the-North-American-Pediatric-Renal-Trials-and-Collaborative-Studies-NAPRTCS-Organization-in-Launching-Prospective-Multi-Center-Pediatric-Kidney-Transplant-Stud.html
Summer.76,
02.12.2021 17:50 Uhr
0
CareDx The Transplant Company Surpasses 80,000 Patient Milestone
https://finance.yahoo.com/news/caredx-transplant-company-surpasses-80-120000159.html
Over 80,000 Heart, Kidney, and Lung Organ Transplant Recipients Have Used AlloSure or AlloMap in their Post-Transplant Care
Summer.76,
10.11.2021 15:57 Uhr
0
CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence
https://finance.yahoo.com/news/caredx-acquires-medactionplan-directly-support-120000499.html
MedActionPlan adds a robust medication adherence platform to the CareDx digital suite, currently used in more than 100 hospitals and health systems
Summer.76,
04.11.2021 16:50 Uhr
0
University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices
https://www.globenewswire.com/news-release/2021/11/04/2327294/31386/en/University-of-Alabama-Integrates-CareDx-s-TxAccess-for-Connection-to-Over-500-Community-Practices.html
TxAccess Supports and Accelerates Patients onto the Transplant Waitlist
Summer.76,
29.10.2021 16:43 Uhr
0
CareDx drops despite Q3 beat amid concerns over regulatory investigations
https://seekingalpha.com/news/3760894-caredx-drops-despite-q3-beat-amid-concerns-over-regulatory-investigations
Summer.76,
28.10.2021 22:07 Uhr
0
CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance
https://www.globenewswire.com/news-release/2021/10/28/2323150/31386/en/CareDx-Reports-Third-Quarter-2021-Results-Increases-Full-Year-Revenue-Guidance.html
...
Recent Highlights:
• Achieved record revenue of $75.6 million for the three months ended September 30, 2021, increasing 42% year-over-year
• Grew testing services volume 86% year-over-year, with approximately 40,000 AlloSure and AlloMap patient results provided in the quarter - highlighted by an approximately 90% attach rate for HeartCare
• Announced publication of KidneyCare validation study in Kidney360 – Multicenter study validating AlloMap and demonstrating the complementary value with AlloSure for detecting rejection
• Received first commercial AlloSure Lung coverage, followed by commercial launch of AlloSure Lung, the first dd-cfDNA test available for lung transplant patients, in October
...
2021 Guidance
For the full year 2021, CareDx now expects revenue to be in the range of $290 million to $293 million (previously $280 million to $290 million).
Summer.76,
21.10.2021 15:51 Uhr
0
CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study
https://www.globenewswire.com/news-release/2021/10/21/2318166/31386/en/CareDx-s-AlloSure-Demonstrates-Better-Accuracy-Than-Current-Standards-of-Care-in-Independent-Kidney-Transplant-Study.html
Landmark Longitudinal Study in Over 1,000 Transplant Patients Confirms AlloSure More Accurately Measures Organ Health
Summer.76,
19.10.2021 15:49 Uhr
0
CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement
https://finance.yahoo.com/news/caredx-eledon-pharmaceuticals-announce-collaborative-110000256.html
Eledon to use AlloSure to help assess the efficacy of AT-1501 in the prevention of rejection in Eledon’s upcoming renal transplantation trials
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | EVOTEC Hauptdiskussion | +2,45 % | |
2 | MicroStrategy | +4,00 % | |
3 | PLUG POWER Hauptdiskussion | -1,71 % | |
4 | Schaeffler new | -0,21 % | |
5 | Lilium Aktie | +3,50 % | |
6 | für alle, die es ehrlich meinen beim Traden. | ||
7 | VW Hauptdiskussion | +0,79 % | |
8 | NEL ASA Hauptdiskussion | -1,30 % | |
9 | TUI Hauptforum | +0,14 % | |
10 | fox e-mobility Hauptdiskussion | +100,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | EVOTEC Hauptdiskussion | +2,60 % | |
2 | PLUG POWER Hauptdiskussion | -2,14 % | |
3 | MicroStrategy | +3,61 % | |
4 | Schaeffler new | -0,84 % | |
5 | Lilium Aktie | +7,69 % | |
6 | VW Hauptdiskussion | +0,05 % | |
7 | NEL ASA Hauptdiskussion | -1,30 % | |
8 | TUI Hauptforum | +0,14 % | |
9 | fox e-mobility Hauptdiskussion | +100,00 % | |
10 | Neues DeFi Technologies Forum | +7,19 % | Alle Diskussionen |